-
When the U.S. Occupational Safety and Health Administration (OSHA) revoked the TB-specific respirator standard Dec. 31, 2003, hospitals began scrambling to make sure they comply with the General Industry Respiratory Protection Standard (1910.134).
-
Underscoring the importance of its new infection control standards for 2005, the Joint Commission on Accreditation of Healthcare Organizations has decided to roll out the new requirements on a consultative basis for hospitals being surveyed from July to December of this year.
-
While much attention has been paid to new hospital infection control standards for 2005, the Joint Commission also is adopting similar standards in long-term care facilities.
-
The Joint Commission and the National Quality Forum (NQF) are accepting applications for the John M. Eisenberg Patient Safety Awards, which recognize individuals and health care organizations that are making significant contributions to improving patient safety.
-
Reliability is the most important performance criteria for phlebotomy devices, but everything from patient care to comfort with the technique influences preferences of frontline users, according to a survey of health care workers by the Safety Institute of Premier Inc., an alliance of hospitals and health systems based in Oak Brook, IL.
-
Baystate Medical Center in Springfield, MA, hasnt vaccinated a single health care worker against smallpox. Yet the hospital is well-prepared for a possible smallpox event with a plan that would allow vaccination of 5,600 employees in a three-day period.
-
A Toronto nurse who contracted severe acute respiratory syndrome (SARS) has sued the city, provincial, and federal governments, asserting that the public health authorities halted precautions too soon and put political considerations above health and safety concerns.
-
-
Medicaid exec: Funds will dry up this summer; KidCare insurance will be cut back.
-
Even as Johnson & Johnsons (New Brunswick, New Jersey) Cordis (Miami Lakes, Florida) unit was rolling out results of a three-year trial of its Cypher drug-eluting stent (DES) during the American College of Cardiology meeting, another study was being reported comparing Cypher with another DES being used in Europe.